Abbott Laboratories Gains Momentum with Key Regulatory Approval
22.12.2025 - 10:23:04Abbott Laboratories US0028241000
Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company has secured U.S. Food and Drug Administration (FDA) and European approvals for its “Amplatzer Piccolo
Delivery System,” a device designed to treat a life-threatening heart condition in premature infants. This milestone reinforces the strength of Abbott’s specialized portfolio within the pediatric cardiology market.
This regulatory success arrives during a period of strategic growth for the healthcare giant. In a major move to bolster its diagnostics division, Abbott announced in Read more...
